Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Brivudine

EU orphan designation number: EU/3/09/703   
Active ingredient: Brivudine
Indication: Treatment of pancreatic cancer
Sponsor: RESprotect GmbH
Fiedlerstraße 34, D-01307 Dresden, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Centralised Orphan - Designation EMEA/OD/105/09 (2010)661 of 28/01/2010